RA
VSTM icon

Rosalind Advisors’s Verastem VSTM Stock Holding History

Rosalind Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-268,600
Closed -$160K – 45
2025
Q4 		$160K Sell
268,600
-377,900
-58% -$3.37M 0.06% 36
2025
Q3 		$898K Buy
+646,500
New +$4.81M 0.31% 32

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FCMV
Foresite Capital Management VI Larkspur, California $643M AUM 343.43% 1-Year Est. Return

Rosalind Advisors's VSTM Position: Q2 2026 in Review

Rosalind Advisors increased its Verastem (VSTM) stake by 86% in Q2 2026, buying an estimated $8.94M and bringing the position to 3,986,509 shares worth $15.2M. The position accounts for 5.66% of the portfolio, ranked #5.

Rosalind Advisors first reported a position in VSTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $17M in Q3 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Rosalind Advisors held 3,986,509 shares of Verastem worth $15.2M as of Q2 2026.
  • Rosalind Advisors bought 1,848,034 Verastem shares in Q2 2026, an estimated $8.94M.
  • Verastem made up 5.66% of Rosalind Advisors's portfolio in Q2 2026, its #5 holding.
  • Rosalind Advisors first reported a position in Verastem in Q4 2024 and has held it in 7 quarters since.
  • Rosalind Advisors's Verastem position peaked at $17M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.